Centaurus Financial Inc. Invests $1.20 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Centaurus Financial Inc. bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 13,408 shares of the exchange traded fund’s stock, valued at approximately $1,197,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. EPG Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after buying an additional 278 shares during the period. BOCHK Asset Management Ltd bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $36,000. Tennessee Valley Asset Management Partners purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $44,000. Wetzel Investment Advisors Inc. bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $45,000. Finally, Concourse Financial Group Securities Inc. increased its stake in shares of SPDR S&P Biotech ETF by 21.2% in the fourth quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock worth $59,000 after purchasing an additional 115 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock traded down $2.07 on Friday, hitting $91.75. 9,218,504 shares of the stock traded hands, compared to its average volume of 10,964,691. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The firm has a 50 day simple moving average of $89.10 and a two-hundred day simple moving average of $89.75. The firm has a market cap of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.